Alpharadin drug - courtesy AlgetaA trial of a new cancer drug, which accurately targets tumors, has been so successful it has been stopped early.

Doctors at London’s Royal Marsden Hospital gave prostate cancer patients a powerful alpha radiation drug and found that they lived longer, and experienced less pain and side effects.

The medics then stopped the trial of 922 people, saying it was unethical not to offer all of them the treatment.

(READ the story in the BBC)

Leave a Reply